Zutectra

Zutectra is a human hepatitis B immunoglobulin used for post-exposure prophylaxis and chronic hepatitis B management. This therapy provides passive immunity against hepatitis B virus. Suitable for subcutaneous administration in adults.

Zutectra is used to prevent hepatitis B virus reinfection in liver transplant patients and to provide protection after known or suspected exposure. It may also be used for chronic hepatitis B carriers during immunosuppressive therapy. This immunoglobulin helps the immune system recognize and neutralize the virus. Always consult a healthcare provider for personalized guidance.

After administration, Zutectra works by supplying antibodies that temporarily boost the body’s immune response to hepatitis B. Users may notice improved protection against infection over time. Effects vary based on individual immune status and exposure risk. Regular use as directed supports long-term immunity.

Store Zutectra refrigerated between 2°C and 8°C and protect from light. Do not freeze. Administer only as prescribed by a healthcare professional. Keep the product in its original packaging until use. Dispose of any unused product properly. Report any adverse reactions to a doctor immediately.

Zutectra may interact with live vaccines, potentially reducing their effectiveness. Avoid concurrent use with immunosuppressants unless directed by a physician. Alcohol and certain medications may affect how the body processes immunoglobulins. Always inform your healthcare provider about all medications and supplements you are taking.